Skip to main content

Find Clinical Trials

Home
Conditions
Neurodegenerative Diseases

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,982 public trials 1,753 recruiting studies

Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

NCT01245530

Conditions: Alzheimer Disease, Alzheimer Type Dementia, Brain Diseases, +7 more
Locations: Whanin Pharm.Co.,Ltd. Seoul, Moonjung, South Korea

View Trial Details

Completed

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

NCT00416169

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +11 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

NCT00236431

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

NCT00035204

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

NCT00236574

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

NCT00253214

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

NCT00082602

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

NCT00645190

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

NCT00309725

Conditions: Alzheimer Disease, Alzheimer's Disease, Arrhythmias, Cardiac, +12 more
Locations: Not specified

View Trial Details

Completed

A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

NCT00253227

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: Not specified

View Trial Details